Penumbra (PEN) Tax Rate Growth (1y) (2015 - 2026)
Penumbra (PEN) Tax Rate Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Penumbra | 12.57 Bn | 11.96 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,126.00 |
| Dec 31, 2025 | 156.00 |
| Sep 30, 2025 | -1,352.00 |
| Mar 31, 2025 | -1,421.00 |
| Dec 31, 2024 | 6,612.00 |
| Sep 30, 2024 | -485.00 |
| Jun 30, 2024 | 1,962.00 |
| Mar 31, 2024 | 2,374.00 |
| Dec 31, 2023 | -8,770.00 |
| Sep 30, 2023 | -14,408.00 |
| Jun 30, 2023 | 21,901.00 |
| Mar 31, 2023 | -10,051.00 |
| Dec 31, 2022 | 576.00 |
| Sep 30, 2022 | 17,803.00 |
| Jun 30, 2022 | -23,460.00 |
| Mar 31, 2022 | 8,919.00 |
| Dec 31, 2021 | -57,522.00 |
| Sep 30, 2021 | -5,315.00 |
| Jun 30, 2021 | -558.00 |
| Mar 31, 2021 | -20,667.00 |